Abstract
The Ras/Raf/MEK/ERK pathway plays a critical role in the transmission of signals from growth factor receptors to the nucleus to regulate gene expression. Components of this pathway (e.g., Ras and B-Raf) are frequently mutated in human cancer. Mutations at upstream receptors (e.g., epidermal growth factor receptor [EGFR] and Flt-3) and chimeric chromosomal translocations (e.g., BCR-ABL), which transmit their signals through the Ras/Raf/MEK/ERK cascade were also frequently observed in human cancer. This pathway also interacts with other signaling pathways (e.g., PI3K/PTEN/Akt) to regulate cell growth. In some cells, mutation of PTEN may contribute to suppression of Raf/MEK/ERK because of the ability of Akt to phosphorylate and inactivate Raf-1. Other regulatory components of the Raf/MEK/ERK pathway (e.g., the Raf Kinase Inhibitor Protein, RKIP) may display altered expression during metastasis, which lead to activation of the pathway. This chapter describes the roles of the Raf/MEK/ERK pathway in signal transduction, prevention of apoptosis and induction of drug resistance.
Original language | English (US) |
---|---|
Title of host publication | Apoptosis, Cell Signaling, and Human Diseases |
Publisher | Humana Press |
Pages | 101-134 |
Number of pages | 34 |
Volume | 2 |
ISBN (Print) | 1588296776, 9781588296771 |
DOIs | |
State | Published - Dec 1 2007 |
Externally published | Yes |
Keywords
- MAPK
- Raf
- apoptosis
- cell cycle
- drug resistance
- signal transduction
ASJC Scopus subject areas
- General Medicine
- General Biochemistry, Genetics and Molecular Biology